Skip to main navigation

Skip to main content

Home
Corporate Governance
Press Releases
Events & Presentations
Stock Info
Stock Quote Stock Chart Historical Stock Quote Analysts
ASX Filings
SEC Filings
Reports
Resources
Investor FAQs Investor Email Alerts Contact Us

Press Releases

Year

Opthea to present at the FLORetina 2022 Congress

December 6, 2022

Chairman's Address to Shareholders

November 16, 2022

Opthea Expands Leadership Team with CFO Appointment

October 25, 2022

Completion of Share Purchase Plan

September 26, 2022

Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights

August 30, 2022

Opthea to Present at H.C. Wainwright 2nd Annual Conference

August 17, 2022

Opthea secures up to US$170m in non-dilutive financing

August 15, 2022

Form 6-K with SEC

August 15, 2022

Opthea Successfully Closes Well Supported US$90 Million Equity Financing

August 14, 2022

Opthea Secures up to US$170 Million in Non-Dilutive Financing for OPT-302 in wet AMD

Carlyle and its life sciences franchise Abingworth, working with their recently formed development company Launch Therapeutics (Launch Tx), to provide non-dilutive financing of up to US$170M, consisting of a US$120M commitment and an option to increase funding by a further US$50M If OPT-302 is

August 14, 2022

Pagination

First page
Previous page
…
Page 5
Page 6
Current page 7
Page 8
Page 9
…
Next page
Last page

Displaying 61 - 70 of 144

Request Email Alerts

If you wish to receive email alerts on company news, please sign up below: